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Abstract
The reovirus fusion-associated small transmembrane (FAST) proteins are virus-encoded membrane fusion proteins that
function as dedicated cell–cell fusogens. The topology of these small, single-pass membrane proteins orients the majority of
the protein on the distal side of the membrane (i.e., inside the cell). We now show that ectopic expression of the
endodomains of the p10, p14, and p15 FAST proteins enhances syncytiogenesis induced by the full-length FAST proteins,
both homotypically and heterotypically. Results further indicate that the 68-residue cytoplasmic endodomain of the p14
FAST protein (1) is endogenously generated from full-length p14 protein expressed in virus-infected or transfected cells; (2)
enhances syncytiogenesis subsequent to stable pore formation; (3) increases the syncytiogenic activity of heterologous
fusion proteins, including the differentiation-dependent fusion of murine myoblasts; (4) exerts its enhancing activity from
the cytosol, independent of direct interactions with either the fusogen or the membranes being fused; and (5) contains
several regions with protein–protein interaction motifs that influence enhancing activity. We propose that the unique
evolution of the FAST proteins as virus-encoded cellular fusogens has allowed them to generate a trans-acting, soluble
endodomain peptide to harness a cellular pathway or process involved in the poorly understood process that facilitates the
transition from microfusion pores to macrofusion and syncytiogenesis.
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Introduction
The formation of multi-nucleated syncytia is an essential feature
of a diverse range of biological processes [1]. Syncytiogenesis is
contingent upon regulated cell–cell membrane fusion, which
requires the involvement of protein catalysts to overcome the
thermodynamic barriers that prevent spontaneous fusion of
biological membranes [2]. The fusion proteins responsible for
cell–cell fusion remain largely undiscovered and/or their mech-
anism of action poorly defined [1,3]. Our current understanding of
protein-mediated membrane fusion derives largely from the study
of enveloped virus proteins designed to promote virus–cell fusion
[4,5], and from the SNARE proteins involved in intracellular
vesicle fusion [6]. These studies converge on what may be a
unifying model of membrane fusion involving a multi-step fusion-
through-hemifusion pathway mediated by dynamic remodelling of
the fusion protein complex [7,8]. While mechanisms by which
membrane fusion proteins promote membrane merger and the
formation of focal fusion pores are beginning to emerge, relatively
little is known about the processes that drive expansion of these
fusion apertures, an essential step for those cell–cell fusion events
that result in syncytium formation [9,10].
The fusogenic orthoreoviruses encode a unique family of
membrane fusion proteins, termed the fusion-associated small
transmembrane (FAST) proteins. There are currently three
distinct members of the FAST protein family named according
to their molecular masses; p10, p14 and p15 [11–13]. Unlike
enveloped virus fusion proteins, the FAST proteins are nonstruc-
tural proteins and are therefore not involved in promoting virus–
cell fusion and virus entry [12,13]. Following their expression
inside virus-infected or transfected cells, the FAST proteins traffic
to the plasma membrane where they perform their sole defined
function, to induce cell–cell fusion and polykaryon formation in a
wide variety of cell types [14]. The FAST proteins therefore
function as promiscuous, virus-encoded ‘‘cellular’’ fusogens. The
FAST proteins are both necessary and sufficient to induce
membrane fusion, they need only be present in one of the two
membranes being fused, and at only 95–140 residues in size, are
the smallest known autonomous fusogens [15,16]. All of the FAST
proteins are single-pass membrane proteins that position very
small N-terminal ectodomains (,20–41 residues) external to the
membrane and relatively larger C-terminal endodomains of ,36–
97 residues in the cytosol [11,13,17]. In contrast, most enveloped
virus fusion proteins and the SNARE proteins are oriented with
the majority of their mass positioned to interact with the proximal
leaflets of the membranes to be fused [4,6,18]. We have been
interested in reconciling the unusual topologies of the FAST
proteins with their role as dedicated cell–cell fusogens.
Although enveloped virus fusion proteins can induce cell–cell
membrane fusion, their primary function is to serve as virus–cell
fusogens; their endodomains are therefore designed to function
from the interior of the virion, not necessarily from the cytoplasm
of the cell. This evolutionary imperative may explain why the
endodomains of many enveloped virus fusion proteins either have
PLoS Pathogens | www.plospathogens.org 1 March 2009 | Volume 5 | Issue 3 | e1000331no essential role in the membrane fusion reaction, or actually serve
to inhibit cell–cell fusion activity, thereby coupling fusion
competence to virion maturation [19–23]. In instances where
the endodomain is required for membrane fusion, it is frequently
involved in subcellular localization of the fusion protein, virus
assembly and/or the formation of stable fusion pores [24–27]. As
nonstructural viral proteins dedicated to executing cell–cell fusion,
the endodomains of the FAST proteins do not need to inhibit
fusion to promote virus assembly, and have specifically evolved to
function during membrane fusion while in contact with the
cytoplasm. These distinct evolutionary imperatives suggest the
endodomains of the FAST proteins, and other yet to be identified
cellular fusogens, might serve a different function during the fusion
process than the endodomains of most enveloped virus fusion
proteins.
The homologous p10 FAST proteins of avian reovirus (ARV)
and Nelson Bay reovirus (NBV) contain 95–98 residues,
distributed approximately equally on either side of the transmem-
brane domain [13]. The p14 FAST protein of reptilian reovirus is
a 125-residue integral membrane protein, with a single trans-
membrane domain that separates a small, 36-residue N-terminal
ectodomain from a considerably larger 68-residue C-terminal
endodomain [11]. The asymmetric membrane topology of p14 is
even more pronounced in the p15 FAST protein of baboon
reovirus, which contains ecto- and endodomains of 20 and 97
residues, respectively [17]. Previous studies indicate that progres-
sive deletion of the C-terminal endodomain of the p14 FAST
protein leads to a progressive loss in cell–cell fusion activity,
implying the C-terminal tail is essential for cell–cell membrane
fusion [11]. The basis for this phenotype, however, has not been
determined. We now show that ectopic expression of the FAST
protein endodomains enhances the syncytiogenic activity of the
full-length FAST proteins, both homotypically and heterotypically.
Results further indicate that the biologically active endodomain
fragment of the p14 FAST protein is endogenously generated from
the full-length protein in virus-infected or transfected cells.
Furthermore, the p14 endodomain peptide, when ectopically
expressed in transfected cells, displays the surprising capacity to
enhance syncytiogenesis mediated by unrelated viral or cellular
fusogens. The syncytium-enhancing ability of the p14 endodomain
is not dependent on interactions with either the fusogen or the
membranes being fused, and occurs downstream of stable fusion
pore formation. The FAST proteins are the first example of viral
membrane fusion proteins that generate a soluble, bioactive
endodomain fragment that presumably stimulates a cellular
process central to the poorly understood sequence of events that
promote the transition of stable fusion pores into syncytia.
Results
The p14 Endodomain Functions as a General Enhancer of
Syncytiogenesis
While analyzing a series of N-terminal truncations of the p14
FAST protein, we made the surprising discovery that co-
expression of the p14 endodomain fragment (that induces no
syncytium formation on its own) with the full-length p14 protein
increased syncytiogenesis. Cells co-transfected with full-length p14
plus the p14 endodomain significantly increased the extent of
syncytium formation relative to cells co-transfected with p14 plus
empty vector, as shown by quantifying syncytial nuclei (Figure 1A,
End construct) and from microscopic examination of transfected
cells (Figure 1B). The p14 endodomain was capable of increasing
the fusogenic activity of the full-length protein, but did not rescue
the fusion-dead N-terminal (DEct) or C-terminal (DEnd) truncated
versions of p14 (data not shown). The enhancing activity of the
p14 endodomain was only significant at early times post-
transfection (,6–8 h for p14), and was not manifested by either
ecto- or endodomain constructs that retained the p14 transmem-
brane domain (Figure 1A). Using the extent of syncytium
formation in cells co-transfected with the p14 expression plasmid
plus empty vector as a baseline, co-transfection of the non-
fusogenic p14 endodomain with authentic p14 increased syncy-
tiogenesis to 60–80% of that obtained in cells transfected with a
double-dose of the full-length protein (Figure 1C). In other words,
the non-fusogenic p14 endodomain functions almost as well as the
full-length protein in enhancing p14-mediated syncytium forma-
tion. An N-terminal FLAG-tagged version of the p14 endodomain
retained enhancement activity (Figure 1C), and Western blotting
with an anti-FLAG antibody was used to confirm expression of the
endodomain in transfected cells (Figure 1D). A scrambled version
of the endodomain exhibited no enhancement capability
(Figure 1C), suggesting this activity is sequence-specific.
To determine whether the bioactive property of the p14
endodomain was generally applicable to members of the FAST
protein family, similar studies were conducted with the endodo-
mains of the p10 and p15 FAST proteins, using both homotypic
and heterotypic co-transfections. Since the kinetics of syncytium
formation for the various FAST proteins varies widely [14], we
determined the time range where doubling the dose of the fusogen
yielded approximately twice the extent of syncytium formation.
The enhancing activity of the endodomain fragments was
quantified during this time range, which varied from 6–15 h
post-transfection for the various FAST proteins. Results are
presented as relative fusion, using cells transfected with a double-
dose of the full-length fusogen as 100% fusion capacity and cells
co-transfected with the fusogen plus empty vector as 0% fusion.
The relative fusion scale accounts both for the varying times and
the different extents of cell fusion mediated by the various FAST
proteins (which ranged from ,60–130 nuclei per field for single
and double doses of p10, respectively, versus ,390–770 syncytial
nuclei per field for p14). Ectopic expression of the p10 and p15
endodomains enhanced syncytiogenesis mediated by their corre-
Author Summary
The reovirus FAST proteins are the only known examples
of nonenveloped virus membrane fusion proteins. Func-
tioning as virus-encoded cellular fusogens, they mediate
cell–cell membrane fusion and syncytium formation rather
than virus–cell fusion. The FAST proteins are also the
smallest protein fusogens and assume an unusual
membrane topology, positioning the majority of their
mass within or internal to the membrane in which they
reside. We have been interested in reconciling the donor
membrane-biased structural features of the FAST proteins
with their ability to orchestrate the multi-step cell–cell
membrane fusion process that leads to syncytium
formation. We now show that the FAST proteins generate
a soluble endodomain fragment that functions in trans
from the cytosol, enhancing the capacity of diverse viral
and cellular fusogens to drive the conversion of fusion
pores into syncytia. The FAST proteins may therefore
function in a similar manner as membrane receptors
whose signalling activity requires regulated intramem-
brane proteolysis to generate a soluble signalling peptide.
The endodomain signalling peptide of the FAST proteins
provides a novel approach to identify cellular effectors
involved in the fusion pore expansion stage of biological
cell–cell membrane fusion.
FAST Protein Endodomains
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compared to the p14 endodomain (Figure 2A), which could reflect
either inherent differences in their enhancement activities or
variable expression levels of the different endodomains. Interest-
ingly, the activity of the various FAST protein endodomains was
not confined to enhancing the activity of the corresponding full-
length protein, since syncytium formation was consistently higher
in cells co-transfected with various combinations of endodomain
and FAST protein than in cells co-transfected with the fusogen
plus empty vector (Figure 2A).
Using the more robust p14 endodomain as the prototype, we
examined the cell-type and fusogen specificity of the endodomain
enhancing activity. The syncytium-enhancing activity of the p14
endodomain was not cell-specific, functioning to approximately
the same degree in human HT1080 fibroblast and monkey Vero
epithelial cells as it did in QM5 quail fibroblasts (Figure 2B). Most
interestingly, the p14 endodomain also enhanced the low pH-
induced syncytium formation mediated by the unrelated influenza
virus hemagglutinin (Figure 2B), and the syncytiogenic activity of
the unidentified, endogenous fusogen(s) responsible for the
differentiation-dependent fusion of C2C12 murine myoblasts into
myotubes (Figure 2C and 2D). The 68-residue, non-membrane–
anchored form of the p14 endodomain therefore has the surprising
ability to function as a general enhancer of syncytiogenesis.
Figure 1. The p14 endodomain peptide enhances p14-induced syncytiogenesis. (A) Top panel: Arrangement of structural motifs in the p14
FAST protein, and the regions present in the N- (DEct) and C- (DEnd) terminally truncated p14 constructs and the endodomain construct (End) are
depicted. HP, hydrophobic patch; TM, transmembrane domain; PB, polybasic region; PP, polyproline region. Bottom panel: QM5 fibroblasts
transfected with a plasmid expressing p14 were co-transfected with plasmids expressing full-length p14 (p14), empty vector (Vec), the p14
endodomain (End), or p14 with a deleted endodomain (DEnd) or deleted ectodomain (DEct), and triplicate samples were quantified for the extent of
cell–cell fusion at 8 h post-transfection. Values are the average number of syncytial nuclei per field6S.E. (n=4). Only the endodomain construct,
indicated with the asterisks, resulted in a statistically significant increase in syncytium formation (p,0.001) relative to the cells co-transfected with
p14 plus empty vector. (B) The extent of syncytium formation present in cells co-transfected with p14 plus empty vector (Vec) or p14 plus the p14
endodomain (End) was visualized by bright field microscopy of Giemsa-stained monolayers at 8 h post-transfection. (C) Cells transfected with the p14
expression plasmid were co-transfected with plasmids expressing authentic p14 (p14), empty vector (Vec), the p14 endodomain (End), or a scrambled
(S-End) or N-terminally FLAG-tagged (F-End) version of the p14 endodomain. The extent of cell–cell fusion was quantified as described in (A), and
results are presented as the relative level of syncytium formation6S.E. (n=4), setting the cells co-transfected with authentic p14 as 100% fusion
enhancement and those co-transfected with empty vector as 0% fusion enhancement. (D) Cell lysates from cells co-transfected with the indicated
expression plasmids (p14, authentic p14; V, empty vector; FE, FLAG-tagged p14 endodomain) at 12 h post-transfection were processed for Western
blotting using antibodies against p14, the FLAG epitope, or b-actin (indicated on the left).
doi:10.1371/journal.ppat.1000331.g001
FAST Protein Endodomains
PLoS Pathogens | www.plospathogens.org 3 March 2009 | Volume 5 | Issue 3 | e1000331Figure 2. The FAST protein endodomains function as general enhancers of syncytium formation. (A) QM5 cells were co-transfected with
plasmids expressing the indicated FAST proteins (NBV p10, p14, or p15) and the indicated endodomain (from p10 (p10E), p14 (p14E) or p15 (p15E)).
The extent of cell–cell fusion was quantified as described in Figure 1A, and results are presented as the relative fusion level6S.E. (n=4), setting the
cells co-transfected with the full-length fusogen as 100% fusion enhancement and those co-transfected with empty vector as 0% fusion
enhancement. Syncytia were quantified during the linear range of the fusion assay (12 h post-transfection for p10; 8 h post-transfection for p14 and
p15). Statistically significant increases in syncytium formation relative to cells co-transfected with fusogen plus empty vector are indicated with
asterisks (*p,0.05; ***p,0.001). (B) HT-1080 (HT) or Vero cells were co-transfected with plasmids expressing p14 and the p14 endodomain, or QM5
cells were co-transfected with the p14 endodomain and influenza virus hemagglutinin (HA). The relative fusion level6S.E. (n=4) was determined as
described in (A). (C) C2C12 murine myoblasts were transfected with the p14 endodomain expression plasmid or empty vector and induced to
undergo differentiation-dependent cell–cell fusion. The extent of syncytium formation at 72 h post-transfection was quantified using a syncytial
index, as described in Figure 1A, and results are reported as the average number of syncytial nuclei per field6S.E. (n=4). (D) As for (C), with the extent
of syncytium formation in C2C12 cells transfected with the p14 endodomain expression plasmid or empty vector visualized by bright field
microscopy of Giemsa-stained monolayers at 72 h post-transfection.
doi:10.1371/journal.ppat.1000331.g002
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Membrane Fusion
A cell–cell pore-forming assay was used to determine whether
the p14 endodomain peptide enhanced syncytiogenesis prior or
subsequent to the formation of stable fusion pores. QM5
fibroblasts co-expressing p14, EGFP and either empty vector or
the p14 endodomain plasmid were co-cultured with Vero cells
labelled with the small aqueous fluor calcein red-orange. The
extent of fusion pore formation was estimated using flow
cytometry to quantify the percent of EGFP-containing donor cells
that acquired calcein red from the target cells. Cells transfected
with vector alone displayed a low level of spontaneous dye transfer
while expression of p14 resulted in a time-dependent increase in
the percent of co-fluorescent cells that coincided with the
appearance of syncytia (Figure 3). In independent experiments,
doubling the dose of p14 resulted in a 1.6–2.2 fold increase in pore
formation (depending on the time point), but unlike the
syncytiogenesis assay, pore formation in cells co-expressing p14
and the endodomain peptide was indistinguishable from cells co-
expressing p14 and empty vector (Figure 3A). In duplicate
experiments conducted in triplicate, examining multiple time
points over the linear time course of the pore formation assay
(Figure 3B), the extent of pore formation in cells expressing p14
plus the endodomain never exceeded that observed in control cells
expressing p14 plus empty vector. The p14 endodomain therefore
has no inherent ability on its own to promote pore formation or
syncytiogenesis, but it displays the remarkable ability to enhance
the syncytiogenic activity of functional p14, and this enhancing
activity exerts its effect subsequent to the formation of stable fusion
pores.
Endogenous In Vivo Generation of the p14 Endodomain
To determine whether the endodomain fragment is naturally
generated in cells transfected with only the full-length p14 protein,
Western blots of p14-transfected cell lysates obtained 12 h post-
transfection were probed using a polyclonal antiserum raised
against the p14 protein. In addition to full-length p14, these blots
clearly detected sub-molar amounts of a p14 fragment whose gel
mobility closely approximated that of the ectopically expressed
p14 endodomain (Figure 4; p14*). In addition, a second, smaller
p14 fragment was detected on some blots (Figure 4; p14**), but at
reduced levels relative to the p14* fragment. Neither of these
fragments (p14* and p14**) was ever detected in lysates from
vector-transfected cells (Figure 4, lane 1). A ten-residue C-terminal
truncation of p14 increased the gel mobility of both the p14 and
p14* polypeptides but not the p14** fragment (Figure 4, lane 4),
while a 21-residue N-terminal truncation eliminated detection of
the p14** fragment with no effect on mobility of the p14*
polypeptide (Figure 4, lane 5). These results suggested proteolytic
processing of the full-length p14 protein generated the p14*
endodomain fragment and the corresponding p14** N-terminal
fragment, which was either further degraded or shed from
membranes resulting in reduced or undetectable steady state
levels of this fragment. Confirmation that p14* represented
endogenous generation of the p14 endodomain was obtained
using a p14 construct containing a C-terminal FLAG tag. Western
blot analysis using an anti-FLAG antibody detected both the p14
and p14* polypeptides but never the p14** fragment (Figure 4,
lane 9). Most notably, a fragment representing the p14
endodomain was also detected in Vero cells infected with reptilian
reovirus (Figure 4, lane 6), and the levels of the p14 endodomains
endogenously generated in transfected or virus-infected cells were
equivalent to, or exceeded, those observed by ectopic expression.
The biological activity displayed by ectopic expression of the p14
endodomain is therefore not due to artificial over-expression of the
peptide, and the same endodomain fragment is endogenously
generated by proteolytic processing of a percentage of the p14
protein at concentrations sufficient to serve as an enhancer of
syncytiogenesis.
Since the p14 endodomain is endogenously generated from the
full-length protein at levels equivalent to those obtained by
exogenous expression and sufficient to be bioactive, this raised the
question as to the relative contribution of the endogenous and
exogenous endodomains to syncytiogenesis. The endogenous and
exogenous endodomains were both detectible at similar levels 12 h
post-transfection (Figure 4A), ,4 h after the time when the
exogenous endodomain exerts a significant enhancing effect on
syncytiogenesis. Expression levels of the endogenous (data not
shown) and exogenous (Figure 4B) endodomains were below
detectible levels by Western blotting at 6–8 h post-transfection,
when syncytial enhancement was evident. Doubling the dose of
the ectopic endodomain resulted in barely detectible levels by 8 h
post-transfection (Figure 4B, lane 3). These results suggested that
low levels of the endodomain are sufficient to exert an enhancing
effect on syncytium formation. This conclusion was further
supported by converting the optimized Kozak consensus sequence
used for translation initiation of the exogenous endodomain
(ACCAUGG) to a sub-optimal sequence (CTTAUGA) [28]. This
change in the translation start site substantially reduced expression
levels of the exogenous endodomain, as shown at 24 h post-
transfection to reveal the low level of expression from the sub-
optimal translation start site (Figure 4C), but had no significant
effect on diminishing fusion enhancement activity (Figure 4D).
The p14 endodomain therefore displays bioactive properties at
low levels of intracellular expression. However, since only a small
percentage of p14 is processed to generate the endodomain, it
seems likely that the endogenous endodomain will exist at sub-
saturating levels at early times post-transfection, which may
explain why ectopic expression enhanced syncytiogenesis at early
times but not at later times when the endogenous endodomain
may reach saturating levels.
The Endodomain Functions as a Soluble Syncytiogenic
Enhancer
A biological and biophysical characterization of the endodo-
main was undertaken to gain some insight into how this peptide
fragment might exert its enhancing activity. Co-expression analysis
indicated the endodomain did not increase the steady-state levels
of p14 (see Figure 1D). To determine whether the p14
endodomain altered cell surface expression of p14, cells were co-
transfected with the p14 endodomain and p14G2A, a fusion-
minus mutant of p14 that displays normal cell surface expression
[11] (p14G2A avoided the complications associated with analyzing
large syncytia by flow cytometry). Live cells were immunostained
using an antiserum specific for the p14 ectodomain. As indicated
(Figure 5A), the endodomain did not enhance syncytiogenesis by
increasing the surface expression of p14. The ability of the p14
endodomain to enhance syncytiogenesis mediated by heterologous
fusogens makes direct physical interactions between the endodo-
main and the fusogen unlikely. This was further confirmed by
immunoprecipitation of the FLAG-tagged endodomain construct
using anti-FLAG antibody, which did not result in co-precipitation
of the full-length p14 protein (Figure 5B). Similar analysis of a
known multimeric protein, p53, provided a positive control for the
co-immunoprecipitation assay (Figure 5B). The p14 endodomain
therefore does not exert its biologically activity via direct
interactions with the fusogen.
FAST Protein Endodomains
PLoS Pathogens | www.plospathogens.org 5 March 2009 | Volume 5 | Issue 3 | e1000331Figure 3. The p14 endodomain functions downstream of stable pore formation. (A) QM5 cells were co-transfected to express p14, EGFP,
and either empty vector (p14+V), the p14 endodomain (p14+E), or full-length p14 (p14+p14), and 3 h post-transfection were over-seeded with Vero
cells labelled with calcein red AM. The cells were co-cultured for 4 h to allow cell–cell fusion to proceed, then trypsinized, and single-cell suspensions
were analyzed by flow cytometry. EGFP-expressing donor cells were gated, and the percent donor cells that acquired calcein red were quantified and
FAST Protein Endodomains
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by immunofluorescence microscopy revealed a diffuse cytosolic/
nuclear staining pattern (Figure 6A). In contrast, and as previously
reported [11], the p14 protein displayed the reticular and surface
staining pattern characteristic of an integral membrane protein.
Subcellular fractionation further indicated the endodomain is a
soluble polypeptide, residing within the cytosolic fraction while
p14 is found exclusively in the membrane fraction of cells
(Figure 6B). Coupled with the observation that the membrane-
anchored version of the endodomain did not augment p14-
induced cell–cell fusion (DEct in Figure 1A), these results imply the
endodomain exerts its enhancement activity independent of direct
interactions with the membranes being fused.
The ability of the endodomain to serve as a general enhancer of
syncytiogenesis, functioning in trans from a separate subcellular
location as the fusogen, suggested the endodomain influences an
intracellular process common to all cell–cell fusion reactions. In
view of the generic role of dynamic actin remodelling on
membrane fusion events [29], we examined whether ectopic
expression of the p14 endodomain resulted in cytoskeletal
rearrangements. Staining F-actin in transfected and non-trans-
fected cells using fluorescent phalloidin revealed no observable
differences in the overall architecture of the actin cytoskeleton
(Figure 7), suggesting that any effects of the endodomain on actin
are not manifested by gross changes in the structure of the
cytoskeleton. This does not preclude the possibility that more
subtle effects of the endodomain on actin distribution might
influence its trans-enhancing activity.
Multiple Regions of the p14 Endodomain Influence
Enhancement Activity
The enhancing activity of the p14 endodomain is sequence-
specific, as indicated by the inability of a scrambled endodomain
construct to enhance cell–cell fusion (see Figure 1C), suggesting a
linear motif may be important in the enhancement mechanism.
The p14 endodomain contains a membrane-proximal polybasic
region (KRRERRR) and a C-proximal polyproline region
(PYEPPSRRKPPPPP) that contains a pentaproline motif and a
PXXP motif, a ligand for SH3 domains [30]. To determine
whether these, or other, motifs might contribute to endodomain
fusion enhancement activity, we conducted an alanine scan,
substituting consecutive groups of three amino acids with alanine
residues. These 23 endodomain mutants were quantitatively
assessed for their enhancing capacity (Figure 8). Western blot
analysis of the FLAG-tagged mutants revealed slight variations in
steady-state levels, but well within the range of expression levels
previously shown to be saturating for enhancement activity (see
Figure 4C). The three alanine mutants spanning the polybasic
region (Figure 8, bars 2–4) had little if any deleterious effect on the
capacity of the endodomain to enhance cell–cell fusion, implying
the polybasic region does not exert a significant effect on the fusion
enhancing activity of the endodomain. Three other regions of the
endodomain were, however, sensitive to alanine substitutions.
Region A lies between the polybasic and polyproline motifs, and
several substitutions in this region had adverse effects on fusion
enhancement (Figure 8, bars 7–11). These substitutions affect two
potential protein kinase A recognition sites (XRX[ST}XXX),
identified using the Eukaryotic Linear Motifs resource (ELM;
http://elm.eu.org). Region B (Figure 8, bars 15–17) occurs in the
endodomain polyproline region; alanine substitutions in this
region that affected the pentaproline motif (Figure 8, bars 17–
19) had no significant effect on enhancement activity while
disruption of the PXXP motif (PAAA; Figure 8, bar 15) severely
restricted enhancement activity. However, the PAAA substitution
affects not only the PXXP motif, but also a predicted src
homology-2 (SH2) ligand motif (YEPP). Mutant 14, which
eliminated the PXXP motif but not the YEPP SH2 domain-
binding motif, was not significantly impaired in its enhanced
syncytiogenic activity (Figure 8), suggesting the potential SH3
domain PXXP ligand motif is unlikely to contribute to the
enhancing activity of the endodomain fragment. All four of the
substitution mutants contained within region C, the extreme C-
terminus of the endodomain, displayed significantly diminished
enhancing activity. This C-terminal region includes potential SH2
(Y[IV]X[VILP]) and PDZ (X[DE]X[IVL] or X[ST]X[VIL])
ligand motifs. Therefore, several regions of the 68-residue p14
ectodomain contain potential linear motifs or structural determi-
nants involved in the ability of this soluble peptide fragment to
function as a general enhancer of syncytiogenesis.
Discussion
The reovirus FAST proteins are a new family of viral fusogens
whose structural and functional properties differ extensively from
the well-characterized fusion proteins encoded by the enveloped
viruses. The unusual topology of the FAST proteins positions
,60–90% of their mass within the transmembrane and endodo-
mains, suggesting the mechanism by which they induce cell–cell
fusion and syncytium formation is particularly focused on the
donor cell, the membrane in which they reside. We recently
demonstrated that the FAST proteins rely on surrogate cellular
adhesins to mediate the membrane attachment and close
apposition stages of the fusion reaction [31]. This observation
provided the first explanation for the exceedingly small size of the
FAST protein ectodomains, which are charged with promoting
the fusion of closely apposed lipid bilayers, not with bringing the
membranes into close proximity. We now show that an additional
explanation for the unusual asymmetric membrane topology of the
FAST proteins reflects the generation of a soluble endodomain
fragment which functions as a general enhancer of syncytium
formation, functioning in trans to promote the conversion of fusion
pores into syncytia. The use of surrogate adhesins coupled with the
generation of a bioactive endodomain peptide presumably reflects
the unique evolution of the FAST proteins as virus-encoded cell–
cell fusogens, allowing these diminutive cell–cell fusogens to
efficiently induce syncytium formation within the confines of their
rudimentary structures.
Since the endodomain fragment is endogenously generated
from full-length p14, both in transfected and virus-infected cells
(Figure 4), it seems likely that the enhancing activity of the
endodomain is relevant to the mechanism of p14-induced
syncytium formation. Additional observations support this specu-
lation. C-terminal residues influence the enhancing, though non-
essential, syncytiogenic activity of the soluble endodomain
(Figure 8). In the context of the full-length protein, C-terminal
plotted versus the forward scatter (FSC). Donor cells transfected with empty vector instead of p14 (Vector) served as a control for fusion-independent
dye transfer. Data is representative of two experiments conducted in triplicate. (B) A time course analysis of the experiment described in (A). The
percent donor cells positive for calcein red, minus the background from vector-transfected donor cells, is graphed as percent pore formation. Results
are the mean6S.D. from a representative experiment in triplicate. Cells were transfected with p14+vector (grey), p14+endodomain (white), or a
double-dose of p14 (black).
doi:10.1371/journal.ppat.1000331.g003
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PLoS Pathogens | www.plospathogens.org 7 March 2009 | Volume 5 | Issue 3 | e1000331Figure 4. Endogenous in vivo generation of the p14 endodomain. (A) Cell lysates from QM5 cells infected with reptilian reovirus (lane 6), or
transfected with empty vector (lanes 1 and 7) or with plasmids expressing the p14 endodomain (End, lane 2), full length p14 (p14, lane 3), a C-
terminal 10-residue (C115, lane 4) or N-terminal 21-residue (DHP, lane 5) truncation of p14, or N- (lane 8) or C- (lane 9) terminally FLAG-tagged
versions of the endodomain or p14 were processed for Western blotting at 20 h post-infection or 12 h post-transfection using antibodies against
p14, the FLAG epitope, or b-actin. The migration of full-length p14, the p14 endodomain (p14*), and the presumed p14 ectodomain (p14**)
fragments are indicated on the right. Lane 5 was spliced in from the same blot as lanes 1–4; lane 6 was spliced in from a separate blot. (B) QM5 cells
were transfected with the indicated amounts of empty vector (Vec) or with the p14 endodomain expression plasmid (End). At 8 or 24 h post-
transfection, cell lysates were harvested and processed for Western blotting using antibodies against p14 or b-actin. (C) QM5 cells were transfected
with the p14 endodomain expression plasmid (End) or with a plasmid expressing p14 from a sub-optimal translation start codon (End*). Cell lysates
were harvested at 24 h post-transfection and processed for Western blotting using antibodies against p14 or b-actin. (D) Cells transfected with 0.5 mg
of the p14 expression plasmid were co-transfected with 0.5 mg of plasmids expressing authentic p14 (p14), empty vector (Vec), the p14 endodomain
(End), or expressing p14 from a sub-optimal translation start codon (End*). The extent of cell–cell fusion in triplicate samples was quantified as
described in Figure 1A, and results are presented as the relative level of syncytium formation6S.D. from a single experiment, setting the cells co-
transfected with authentic p14 as 100% fusion enhancement and those co-transfected with empty vector as 0% fusion enhancement.
doi:10.1371/journal.ppat.1000331.g004
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fragment (Figure 4), simultaneously reduces the rate, but not the
final extent, of p14-induced syncytiogenesis by ,50% [11]. The
C-terminus of the full-length p14 protein therefore enhances
syncytiogenic activity, and this same region is essential for the trans-
acting activity of the soluble endodomain. Results further indicate
that low steady state levels of the endodomain are all that is
required for biological activity (Figure 4). The sensitivity of
Western blots was not sufficient to correlate fusion enhancement
activity with the steady state levels of the exogenous and
endogenous endodomains at early time points. Nonetheless,
intracellular concentrations of the endogenously generated
endodomain exceed bioactive levels at slightly later time points,
consistent with the concept that the enhancing activity of the
soluble endodomain is relevant to the natural function of p14 as a
cell–cell fusogen. The expression data also serves to explain why
ectopic endodomain expression would augment the enhancement
activity of the endogenous soluble endodomain, functioning at
early times post-transfection to increase the rate at which the
soluble endodomain accumulates to bioactive levels inside cells.
In addition to the C-terminus, other regions of the endodomain
that affect its enhancing activity contain potential protein–protein
interaction motifs (Figure 8). The degenerate nature of the
consensus sequences for these motifs makes it unclear whether
the endodomain deletion and substitution results reflect disruption
of a specific linear motif or global changes to the endodomain
structure. If specific linear motifs do contribute to endodomain
function, then predicted protein kinase A sites and SH2 and PDZ
domain-binding motifs present in the p14 endodomain may be
involved. These motifs are widely involved in diverse cell signalling
pathways that could influence the efficiency by which the cell
promotes the conversion of fusion pores to syncytia [32–35]. Since
all of the FAST protein endodomains appear to contain at least
some level of trans-enhancing activity (Figure 2A), it seems
reasonable to assume they might function through the same
cellular pathway. It also seems reasonable to assume that the
potential protei–protein interactions motifs identified in the p14
endodomain alanine scan might be conserved in the FAST protein
endodomains, even though the FAST protein endodomains lack
any extended regions of direct sequence conservation. An ELM
scan of the p10 and p15 endodomains identified numerous
potential protein interaction or post-translational modification
motifs. The only common motifs identified in all three endodo-
mains were different classes of PDZ domain ligands, which occur
at the C-terminus of p14 and p10, but internally in the p15
endodomain. Whether these motifs are relevant to the bioactive
property of the endodomain and if so, how mutations outside these
motifs influence their role in protein interactions remains to be
determined. NMR structural analyses of the FAST protein
endodomains coupled with pull-down assays are currently
underway to assist in interpretation of the mutagenic analyses
and to identify cellular partners that may serve as effectors of
endodomain bioactivity.
There are no direct parallels in the viral membrane fusion
protein field to the trans-acting enhancement activity of the p14
endodomain. There are examples where enveloped viral fusion
proteins are proteolytically cleaved, for example the maturation
cleavage involved in the assembly stage of several retroviruses
[36,37]. In this instance, cleavage activates the fusion complex by
removal of an inhibitory C-terminal peptide, rather than by
generating a functional peptide fragment. Similar to the trans-
enhancing activity of the soluble p14 endodomain, an artificially
truncated version of the fusogenic vesicular stomatitis virus G
protein comprised of the endodomain, transmembrane domain
and a fragment of the ectodomain enhances the fusion activity of
heterologous fusogens [38]. However, this membrane-anchored
Figure 5. The endodomain functions as a fusion enhancer independent of direct interactions with the fusogen. (A) Top panel: Live
cells co-transfected with p14G2A and the p14 endodomain (black lines) or empty vector (grey lines) were immunostained using anti-p14ecto
antiserum and analysed by flow cytometry. Grey-filled histogram represents auto-fluorescence from mock-transfected cells. Bottom panel: Surface
expression of p14G2A at 8 h and 24 h post-transfection in cells co-transfected with empty vector (Vec) or the p14 endodomain (End), as determined
by flow cytometry and Overton subtraction relative to mock-transfected cells. Numbers indicate the mean fluorescence intensity increase above
mock-transfected cells6S.D. from a representative experiment in triplicate. (B) Cells were co-transfected with the indicated expression plasmids (p14,
authentic p14; V, empty vector; FE, FLAG-tagged endodomain; p53, authentic p53; Fp53, FLAG-tagged p53), and cell lysates were
immunoprecipitated using anti-FLAG antibody. The immunoprecipitates (IP) and unfractionated cell lysates (L) were processed for Western blotting
using anti-p14 (top panel) or anti-p53 (bottom panel) antibodies. The top arrow in the bottom panel indicates the migration of FLAG-tagged p53 and
the bottom arrow untagged p53.
doi:10.1371/journal.ppat.1000331.g005
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and/or hemifusion stages of the fusion reaction, which is clearly
not the case with the soluble p14 endodomain peptide that
functions in an indirect manner, independent of direct membrane
interactions, to promote fusion pore expansion. In C. elegans, the
Eff-1 fusogen involved in developmental epithelial cell–cell fusion
generates a soluble ectodomain fragment that enhances syncytio-
genesis [3,9]. This fragment has no demonstrated role in
Figure 6. The p14 endodomain is a soluble nucleocytoplasmic peptide. (A) Cells were co-transfected with HA-tagged p14 and FLAG-tagged
p14 endodomain, fixed and permeabilized at 8 h post-transfection, and stained using rabbit anti-HA and mouse anti-FLAG antibodies and
appropriate fluorescently tagged secondary antibodies. The HA-tagged p14 (left panel) exhibited punctate, reticular staining in the cytoplasm while
the FLAG-tagged p14 endodomain (right panel) was broadly distributed throughout the cytosol and nucleus. Scale bar=20 mm. (B) Cells were co-
transfected with the indicated expression plasmids (p14, full-length p14; V, empty vector; FE, FLAG-tagged p14 endodomain), and cell lysates were
fractionated into the cytosolic ‘‘C’’ and membrane ‘‘M’’ fractions before being processed for Western blotting using anti-p14 or anti-FLAG antibodies
(indicated on the left).
doi:10.1371/journal.ppat.1000331.g006
Figure 7. The actin cytoskeleton is unaffected by the p14 endodomain. QM5 cells were transfected with the FLAG-tagged p14 endodomain,
and immunostained using anti-FLAG antibody and fluorescently tagged secondary antibody (A). F-actin was visualized by staining with FITC-
phalloidin (B,C). A transfected cell expressing the FLAG-tagged p14 endodomain and an adjoining cell either not transfected or expressing
undetectable levels of the endodomain ((A), lower and upper cells, respectively) exhibited similar arrangements of F-actin, as detected using FITC-
phalloidin (B), and the same actin organization was observed in mock-transfected cells (C). Scale bar=10 mm.
doi:10.1371/journal.ppat.1000331.g007
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unlikely that it would function from the extracellular milieu in a
similar manner as the cytosolic p14 endodomain. The features of
the trans-acting activity of the p14 endodomain are therefore
unique amongst both viral and cellular fusogens.
While the precise mechanism by which the soluble FAST
protein endodomains enhance syncytiogenesis remains to be
determined, several features of this mechanism are apparent.
Coupled with observations from other studies, these results provide
some interesting into insights into this remarkable biological
activity. The ability of the endodomain to enhance syncytiogenesis
mediated by the influenza HA fusogen (which occurs within
minutes after triggering by treatment with low pH), and the
gradual cell–cell fusion induced by the FAST proteins and the
endogenous fusogens responsible for myoblast fusion, which
induce fusion over hours or days, suggests the effects of the
endodomain are constant and sustained over time. Expression of
the endodomain did not alter overall cell function since cell
morphology and growth properties were not affected (Figure 7),
suggesting the p14 endodomain likely functions in a somewhat
specific manner. Furthermore, low steady state levels of the
endodomain are all that is required to enhance a step in syncytium
formation that occurs after formation of stable fusion pores
(Figures 3 and 4) in a manner that is not dependent on direct
physical interactions with either the fusogen or the membranes
being fused (Figures 5 and 6). Taken together, the most
straightforward explanation for the ability of the p14 endodomain
to function as a general enhancer of syncytiogenesis is that the
endodomain functions as a signalling peptide to activate or recruit
an intracellular pathway broadly involved in the conversion of
cell–cell fusion pores to syncytia.
We know of no system where the mechanism by which fusion
pores expand into syncytia has been clearly defined. In C. elegans,
epithelial cell fusion has been kinetically divided into two distinct
stages designated microfusion, the actual membrane fusion event
that results in rapid and stable pore formation, and macrofusion, a
slower pore expansion stage required for syncytium formation
[9,10]. A similar, kinetically distinct two-stage process has been
demonstrated to occur during yeast mating, where fusion pores
(i.e. microfusion) open quickly and reversibly, followed by slow
expansion and macrofusion [39]. Various explanations for how
fusion pores might expand to the macrofusion stage have been put
forward. These scenarios include, but are not limited to,
membrane removal by vesiculation [10], lateral membrane tension
[39], direct or indirect effects of the fusion protein itself [7,25], and
actin-driven effects on membrane tension [29,40]. There is also
evidence that the rate of pore expansion is influenced by the cell
type [25], suggesting there are cellular pathways that directly
influence the macrofusion stage of syncytiogenesis. We therefore
propose that the soluble endodomains of the FAST proteins
harness a cellular pathway involved in driving the transition from
microfusion to macrofusion, perhaps the most energy demanding
stage of syncytiogenesis [2,23].
There are interesting parallels between the ability of the FAST
proteins to generate a bioactive, soluble endodomain peptide, and
membrane receptors and ligands that undergo regulated intra-
membrane proteolysis (RIP) [41,42]. Proteins such as sterol-
regulatory-element–binding protein (SREBP) and the Notch
receptor are two well-characterized examples of membrane
protein substrates that undergo RIP to mediate membrane-to-
nucleus signalling. Cleavage by intramembrane cleaving proteases
(iCLIPs), such as the presenilin/c-secretase complex or the site-2
protease, results in release of a bioactive cytoplasmic domain that
translocates to the nucleus to initiate signalling cascades that
regulate lipid metabolism or diverse cell differentiation processes
[43–45]. We note that the endogenously generated p14 endodo-
Figure 8. Multiple regions of the p14 endodomain affect trans-enhancing activity. Every amino acid of the p14 endodomain, in groups of
three consecutive residues (indicated along the x-axis), was substituted with alanine. These endodomain alanine mutants (numbered 1–23) were co-
expressed with authentic p14 in co-transfected QM5 cells, and the relative fusion level6S.E. (n=4) was determined as described in Figure 1C. Three
regions, ‘‘A’’, ‘‘B’’, ‘‘C’’, where alanine substitutions resulted in a more pronounced inhibitory effect on the trans-potentiation activity of the
endodomain, are indicated on the graph. p14 constructs displaying a significant decrease (p,0.05) in fusion enhancement activity (*), and those
approaching (p,0.06) statistical significance (‘), are indicated. Western blots with anti-FLAG antibodies were used to assess expression levels of the
various FLAG-tagged endodomain mutants, using actin blots as a loading control.
doi:10.1371/journal.ppat.1000331.g008
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ectopically expressed endodomain (Figure 4), suggesting that p14
may also be processed within its transmembrane domain by
iCLIPs to generate the bioactive endodomain peptide. Since the
soluble p14 endodomain exists as a nucleocytoplasmic peptide
(Figure 6), interaction with cellular proteins in either compartment
could alter cellular signalling pathways important in the process
that drives expansion of cell–cell fusion pores. Although the
soluble endodomain clearly has trans-acting activity, only a small
percent of p14 is processed to generate the soluble endodomain. It
therefore seems likely that the endodomains of the FAST proteins
may also function in cis to influence cell–cell fusion activity. A
similar dual cis/trans function has been proposed for other type I
membrane proteins that undergo RIP, for instance the Notch
receptor ligand Jagged-1 that interacts in cis with proteins involved
in organizing cell–cell junctions while functioning in trans as a
signalling peptide [46,47].
The FAST proteins are the first example of a fusion protein that
naturally generates a trans-acting subunit capable of modulating a
cellular pathway or process that may be common to all biological
cell–cell fusion events. By promoting the transition of fusion pores
into syncytia, the trans-acting activity of the C-terminal tail of the
FAST proteins allows these simple cell–cell fusogens to efficiently
induce syncytium formation within the confines of their rudimen-
tary structures. Clearly, numerous questions regarding the function
of the FAST protein endodomains remain to be addressed. What, if
any, cis-acting role is exerted by the endodomain? What regulates
p14 processing and why is only a small percentage cleaved? Does
the soluble endodomain exert its enhancing activity from the
cytoplasm and/or nucleus? What cellular partners interact with the
soluble endodomain, what pathways are regulated by these
partners, and how do these pathways promote fusion pore
expansion and syncytium formation? Most importantly, the general
enhancing activity of the p14 endodomain suggests that discovering
the effectors regulated by the p14 endodomain may provide insights
into cellular pathways that are central to the process of cell–cell
fusion in a diversity of biological processes.
Materials and Methods
Clones
The cDNA clones of the NBV p10, p14, and p15 FAST
proteins in pcDNA3 (Invitrogen) were previously described [11–
13]. Standard PCR techniques were used to generate the p10 and
p15 endodomain constructs, and the p14 endodomain (End,
residues 58–125), scrambled p14 endodomain (SEnd), N- (DEct,
residues 35–125) and C- (DEnd, residues 1–78) terminally
truncated p14, and N- (EDN, residues 35–125) and C- (EDC,
residues 1–78) terminally truncated p14 endodomain expression
plasmids. Each N-terminal truncation included an additional
alanine residue immediately following the initiator methionine, a
consequence of optimizing the context of the translation start site
[13]. The p14 endodomain was subjected to alanine scan
mutagenesis, substituting consecutive groups of three amino acids
with alanine residues, using nested primers and standard PCR
techniques. All constructs were confirmed by sequencing. The
influenza hemagglutinin (strain X-31) was a gift from Judy White,
and was subcloned into pcDNA3. The N-terminal 36 FLAG-
tagged p14 endodomain (F-End) construct was obtained by
subcloning into pBICEP (Sigma).
Cells and Reagents
QM5 and Vero cells were grown and maintained as previously
described [11]. HT1080 and C2C12 cells were cultured in MEM
or DMEM, respectively, supplemented with penicillin/streptomy-
cin (50 mg/ml) and 10% FBS. The C2C12 myoblasts were
induced to differentiate into myotubes by culturing the cells in
DMEM supplemented with 2% horse serum for 72 h. The rabbit
antiserum against full-length p14 was previously described [11].
Rabbit antiserum against the p14 ectodomain (residues 1–36) was
prepared by New England Peptide (anti-p14ecto). Mouse anti-
FLAG antibodies (Sigma), horseradish peroxidase-conjugated goat
anti-rabbit (KPL) and goat anti-mouse (Jackson ImmunoResearch)
secondary antibodies, Alexa-488-conjugated goat anti-rabbit IgG
and Alexa-555-conjugated goat anti-mouse IgG secondary
antibodies (Invitrogen) were from the indicated commercial
sources. FITC-conjugated phalloidin was from Molecular Probes.
Transfection and Syncytial Index
Cells at 70–80% confluency in 12-well cluster plates were
transfected or co-transfected with equivalent quantities (0.5 mg) of
the various expression plasmids using Lipofectamine (Invitrogen),
then supplemented with appropriate serum-containing medium
5 h post-transfection. Transfected cells were fixed at different
times post-transfection based on control experiments that
determined the linear dose-response range (i.e., cells transfected
with 1 mg of the p14 expression plasmid yielded twice the level of
fusion as cells transfected with 0.5 mg of the same plasmid). Cells
expressing HA were trypsin-activated and fusion was induced by
low pH treatment as previously described [31]. A syncytial index
from triplicate samples was determined as previously described
[14], by microscopic examination to quantify the average number
of syncytial nuclei per field from five random fields of the Giemsa-
stained monolayers. The syncytial index was converted to a
relative fusion scale to permit comparisons between replicate
experiments (n.3) using the formula (Cfe2Cfv/Cff2CeV)6100.
This formula sets cells co-transfected with the fusogen plus empty
vector (Cfv) as the baseline and cells transfected with a double-dose
of the fusogen (Cff) as the maximum possible extent of fusion
(100%), and quantifies the extent to which cells co-transfected with
the fusogen plus the p14 endodomain (Cfe) approach the fusion
maximum. Results were analyzed using a two-tailed unlinked t-test
to determine statistical significance.
Western Blotting
QM5 cells were lysed in RIPA buffer (50 mM Tris, pH 8.0,
150 mM NaCl, 1 mM EDTA, 1% Igepal, 0.5% SDS) at 8–24 h
post-transfection and equivalent protein loads were analyzed by
Western blotting, as previously described [13]. Cell lysates were
similarly prepared from cells infected with reptilian reovirus [48]
for 20 h. For detection of the sub-molar, endogenously generated
endodomain fragment, the anti-p14 antiserum was used at 1:3000
dilution instead of 1:10,000.
FACS-Based Fusion Assay
Sub-confluent monolayers of QM5 fibroblasts were co-trans-
fected with plasmids expressing p14 and EGFP and either empty
vector or the p14 endodomain plasmid. At 4 h post-transfection,
these cells were overlaid with Vero cells (5:1 ratio of Vero to QM5)
labelled with 20 mM calcein red-orange AM (Molecular Probes).
The two cell populations were co-cultured at 37uC to allow fusion
to proceed. At various times (2–4 h), the cell cultures were
detached from the substratum, fixed and analyzed by flow
cytometry (FACSCalibur (Becton Dickinson)) using appropriate
filter sets and Cell Quest software. EGFP-positive donor cells were
gated, and the percent of these donor cells that acquired calcein
red was quantified. A minimum of 10,000 events were recorded,
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Software).
Cell Surface Expression
Cells were co-transfected with p14G2A, a fusion-minus mutant
of p14 that displays normal cell surface expression (this mutant was
used to avoid the complication of trying to analyze large syncytia
by flow cytometry) and either empty vector or the p14
endodomain. Transfected cells were washed with PBS supple-
mented with 5% BSA at 8–24 h post-transfection, and cells were
then incubated with 1:200 dilution of anti-p14ecto antiserum
followed by 1:2000 dilution of Alexa-647–conjugated goat anti-
rabbit antibody. Cells were detached from the substratum with
50 mM EDTA in PBS and analysed by flow cytometry.
Fluorescent Immunomicroscopy
Transfected cells grown on gelatin-coated coverslips were fixed
at various times post-transfection using 3.7% formaldehyde, and
permeabilized with 0.1% Triton X-100. The cells were blocked
with normal goat serum, then stained using rabbit anti-HA and
mouse anti-FLAG antibodies (1:200 and 1:2000, respectively) and
Alexa-488–conjugated goat anti-rabbit IgG and Alexa-555–
conjugated goat anti-mouse IgG (Invitrogen). Images were
captured using a Zeiss META 510 confocal microscope.
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